Bolt Biotherapeutics Inc.: Q3 Earnings Snapshot
The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 36 cents per share. The company posted revenue of $1.1 ...
Hosted on MSN6d
Bolt Biotherapeutics, Inc. (BOLT) Reports Q3 Loss, Tops Revenue Estimates
Bolt Biotherapeutics, Inc. (BOLT) came out with a quarterly loss of $0.40 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to loss of $0.43 per share a year ago. These ...